Peripheral CD8+ T Cell Tolerance to Self-Proteins Is Regulated Proximally at the T Cell Receptor

Immunity

Volumn 28, Issue 5, 2008, Pages 662-674

  Teague, Ryan M ^a,b   Greenberg, Philip D ^a,b   Fowler, Carla ^a,b   Huang, Maria Z ^a   Tan, Xiaoxia ^a,b   Morimoto, Junko ^a,b   Dossett, Michelle L ^a,b   Huseby, Eric S ^a   Öhlén, Claes ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; LYMPHOCYTE ACTIVATION; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SELF TOLERANCE; SIGNAL TRANSDUCTION;

EID: 43049179817     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.03.012     Document Type: Article

References (52)

1. Aichele P., Brduscha-Riem K., Zinkernagel R.M., Hengartner H., and Pircher H. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 182 (1995) 261-266
2. Antia R., Ganusov V.V., and Ahmed R. The role of models in understanding CD8+ T-cell memory. Nat. Rev. Immunol. 5 (2005) 101-111
3. Blattman J.N., Grayson J.M., Wherry E.J., Kaech S.M., Smith K.A., and Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9 (2003) 540-547
4. Casanova J.L., Romero P., Widmann C., Kourilsky P., and Maryanski J.L. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: Implications for T cell allelic exclusion and antigen-specific repertoire. J. Exp. Med. 174 (1991) 1371-1383
5. Cheng L.E., and Greenberg P.D. Selective delivery of augmented IL-2 receptor signals to responding CD8+ T cells increases the size of the acute antiviral response and of the resulting memory T cell pool. J. Immunol. 169 (2002) 4990-4997
6. Chiodetti L., Choi S., Barber D.L., and Schwartz R.H. Adaptive tolerance and clonal anergy are distinct biochemical states. J. Immunol. 176 (2006) 2279-2291
7. Daniels M.A., Schober S.L., Hogquist K.A., and Jameson S.C. Cutting edge: A test of the dominant negative signal model for TCR antagonism. J. Immunol. 162 (1999) 3761-3764
8. Danke N.A., Koelle D.M., Yee C., Beheray S., and Kwok W.W. Autoreactive T cells in healthy individuals. J. Immunol. 172 (2004) 5967-5972
9. DeSilva D.R., Urdahl K.B., and Jenkins M.K. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147 (1991) 3261-3267
10. Dittel B.N., Stefanova I., Germain R.N., and Janeway Jr. C.A. Cross-antagonism of a T cell clone expressing two distinct T cell receptors. Immunity 11 (1999) 289-298
11. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4 (2004) 941-952
12. Gascoigne N.R., and Zal T. Molecular interactions at the T cell-antigen-presenting cell interface. Curr. Opin. Immunol. 16 (2004) 114-119
13. Gil D., Schamel W.W., Montoya M., Sanchez-Madrid F., and Alarcon B. Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation. Cell 109 (2002) 901-912
14. Gladow M., Uckert W., and Blankenstein T. Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors. Eur. J. Immunol. 34 (2004) 1882-1891
15. Grayson J.M., Harrington L.E., Lanier J.G., Wherry E.J., and Ahmed R. Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo. J. Immunol. 169 (2002) 3760-3770
16. Grossman Z., and Paul W.E. Adaptive cellular interactions in the immune system: The tunable activation threshold and the significance of subthreshold responses. Proc. Natl. Acad. Sci. USA 89 (1992) 10365-10369
17. Guillaume S., Tuosto L., Tanchot C., Di Bartolo V., Acuto O., and Rocha B. Proximal changes in signal transduction that modify CD8+ T cell responsiveness in vivo. Eur. J. Immunol. 33 (2003) 2551-2556
18. Hah C., Kim M., and Kim K. Induction of peripheral tolerance in dual TCR T cells: An evidence for non-dominant signaling by one TCR. J. Biochem. Mol. Biol. 38 (2005) 334-342
19. Hardardottir F., Baron J.L., and Janeway Jr. C.A. T cells with two functional antigen-specific receptors. Proc. Natl. Acad. Sci. USA 92 (1995) 354-358
20. Heath W.R., and Miller J.F. Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice. J. Exp. Med. 178 (1993) 1807-1811
21. Heemskerk M.H., Hoogeboom M., Hagedoorn R., Kester M.G., Willemze R., and Falkenburg J.H. Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer. J. Exp. Med. 199 (2004) 885-894
22. Hughes M.S., Yu Y.Y., Dudley M.E., Zheng Z., Robbins P.F., Li Y., Wunderlich J., Hawley R.G., Moayeri M., Rosenberg S.A., and Morgan R.A. Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. Hum. Gene Ther. 16 (2005) 457-472
23. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., and Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194 (2001) 669-676
24. Janes P.W., Ley S.C., and Magee A.I. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J. Cell Biol. 147 (1999) 447-461
25. Janes P.W., Ley S.C., Magee A.I., and Kabouridis P.S. The role of lipid rafts in T cell antigen receptor (TCR) signalling. Semin. Immunol. 12 (2000) 23-34
26. Kusmartsev S., Nagaraj S., and Gabrilovich D.I. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. J. Immunol. 175 (2005) 4583-4592
27. Lo D., Burkly L.C., Widera G., Cowing C., Flavell R.A., Palmiter R.D., and Brinster R.L. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 53 (1988) 159-168
28. Lohman B.L., Razvi E.S., and Welsh R.M. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J. Virol. 70 (1996) 8199-8203
29. Morahan G., Allison J., and Miller J.F. Tolerance of class I histocompatibility antigens expressed extrathymically. Nature 339 (1989) 622-624
30. Morgan R.A., Dudley M.E., Wunderlich J.R., Hughes M.S., Yang J.C., Sherry R.M., Royal R.E., Topalian S.L., Kammula U.S., Restifo N.P., et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314 (2006) 126-129
31. Morimoto J., Tan X., Teague R.M., Ohlen C., and Greenberg P.D. Induction of tolerance in CD8+ T cells to a transgenic autoantigen expressed in the liver does not require cross-presentation. J. Immunol. 178 (2007) 6849-6860
32. Murtaza A., Nugent C.T., Tailor P., Asensio V.C., Biggs J.A., Campbell I.L., and Sherman L.A. Altered functional and biochemical response by CD8+ T cells that remain after tolerance. Int. Immunol. 13 (2001) 1085-1093
33. Niederberger N., Holmberg K., Alam S.M., Sakati W., Naramura M., Gu H., and Gascoigne N.R. Allelic exclusion of the TCR alpha-chain is an active process requiring TCR-mediated signaling and c-Cbl. J. Immunol. 170 (2003) 4557-4563
34. Ohlen C., Kalos M., Hong D.J., Shur A.C., and Greenberg P.D. Expression of a tolerizing tumor antigen in peripheral tissue does not preclude recovery of high-affinity CD8+ T cells or CTL immunotherapy of tumors expressing the antigen. J. Immunol. 166 (2001) 2863-2870
35. Ohlen C., Kalos M., Cheng L.E., Shur A.C., Hong D.J., Carson B.D., Kokot N.C., Lerner C.G., Sather B.D., Huseby E.S., and Greenberg P.D. CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J. Exp. Med. 195 (2002) 1407-1418
36. Padovan E., Casorati G., Dellabona P., Meyer S., Brockhaus M., and Lanzavecchia A. Expression of two T cell receptor alpha chains: Dual receptor T cells. Science 262 (1993) 422-424
37. Pardoll D. Does the immune system see tumors as foreign or self?. Annu. Rev. Immunol. 21 (2003) 807-839
38. Ramsdell F., and Fowlkes B.J. Maintenance of in vivo tolerance by persistence of antigen. Science 257 (1992) 1130-1134
39. Robertson J.M., and Evavold B.D. Cutting edge: Dueling TCRs: Peptide antagonism of CD4+ T cells with dual antigen specificities. J. Immunol. 163 (1999) 1750-1754
40. Rocha B., Tanchot C., and Von Boehmer H. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp. Med. 177 (1993) 1517-1521
41. Roszkowski J.J., Lyons G.E., Kast W.M., Yee C., Van Besien K., and Nishimura M.I. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer Res. 65 (2005) 1570-1576
42. Rouquette-Jazdanian A.K., Foussat A., Lamy L., Pelassy C., Lagadec P., Breittmayer J.P., and Aussel C. Cholera toxin B-subunit prevents activation and proliferation of human CD4+ T cells by activation of a neutral sphingomyelinase in lipid rafts. J. Immunol. 175 (2005) 5637-5648
43. Singh N.J., and Schwartz R.H. The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells. J. Exp. Med. 198 (2003) 1107-1117
44. Stanislawski T., Voss R.H., Lotz C., Sadovnikova E., Willemsen R.A., Kuball J., Ruppert T., Bolhuis R.L., Melief C.J., Huber C., et al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat. Immunol. 2 (2001) 962-970
45. Steinman L. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194 (2001) F27-F30
46. Stotz S.H., Bolliger L., Carbone F.R., and Palmer E. T cell receptor (TCR) antagonism without a negative signal: Evidence from T cell hybridomas expressing two independent TCRs. J. Exp. Med. 189 (1999) 253-264
47. Tanchot C., Guillaume S., Delon J., Bourgeois C., Franzke A., Sarukhan A., Trautmann A., and Rocha B. Modifications of CD8+ T cell function during in vivo memory or tolerance induction. Immunity 8 (1998) 581-590
48. Tanchot C., Barber D.L., Chiodetti L., and Schwartz R.H. Adaptive tolerance of CD4+ T cells in vivo: Multiple thresholds in response to a constant level of antigen presentation. J. Immunol. 167 (2001) 2030-2039
49. Teague R.M., Sather B.D., Sacks J.A., Huang M.Z., Dossett M.L., Morimoto J., Tan X., Sutton S.E., Cooke M.P., Ohlen C., and Greenberg P.D. Interleukin-15 rescues tolerant CD8(+) T cells for use in adoptive immunotherapy of established tumors. Nat. Med. 12 (2006) 335-341
50. Valitutti S., Muller S., Cella M., Padovan E., and Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375 (1995) 148-151
51. Yang W., and Grey H.M. Study of the mechanism of TCR antagonism using dual-TCR-expressing T cells. J. Immunol. 170 (2003) 4532-4538
52. Zal T., Weiss S., Mellor A., and Stockinger B. Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function. Proc. Natl. Acad. Sci. USA 93 (1996) 9102-9107